Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis.

Shapiro MR, Wasserfall CH, McGrail SM, Posgai AL, Bacher R, Muir A, Haller MJ, Schatz DA, Wesley JD, von Herrath M, Hagopian WA, Speake C, Atkinson MA, Brusko TM.

Diabetes. 2020 Mar;69(3):413-423. doi: 10.2337/db19-0942. Epub 2019 Dec 11.

PMID:
31826866
2.

Prospective virome analyses in young children at increased genetic risk for type 1 diabetes.

Vehik K, Lynch KF, Wong MC, Tian X, Ross MC, Gibbs RA, Ajami NJ, Petrosino JF, Rewers M, Toppari J, Ziegler AG, She JX, Lernmark A, Akolkar B, Hagopian WA, Schatz DA, Krischer JP, Hyöty H, Lloyd RE; TEDDY Study Group.

Nat Med. 2019 Dec;25(12):1865-1872. doi: 10.1038/s41591-019-0667-0. Epub 2019 Dec 2.

PMID:
31792456
3.

Addressing health disparities in type 1 diabetes through peer mentorship.

Walker AF, Haller MJ, Gurka MJ, Morris HL, Bruggeman B, Miller K, Foster N, Anez Zabala C, Schatz DA.

Pediatr Diabetes. 2020 Feb;21(1):120-127. doi: 10.1111/pedi.12935. Epub 2019 Nov 6.

PMID:
31617648
4.

Temporal Analysis of Amylase Expression in Control, Autoantibody-Positive, and Type 1 Diabetes Pancreatic Tissues.

Kusmartseva I, Beery M, Hiller H, Padilla M, Selman S, Posgai A, Nick HS, Campbell-Thompson M, Schatz DA, Haller MJ, Wasserfall CH, Atkinson MA.

Diabetes. 2020 Jan;69(1):60-66. doi: 10.2337/db19-0554. Epub 2019 Oct 9.

PMID:
31597639
5.

Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome.

Russell JT, Roesch LFW, Ördberg M, Ilonen J, Atkinson MA, Schatz DA, Triplett EW, Ludvigsson J.

Nat Commun. 2019 Aug 9;10(1):3621. doi: 10.1038/s41467-019-11460-x.

6.

Designing Online and Mobile Diabetes Education for Fathers of Children With Type 1 Diabetes: Mixed Methods Study.

Albanese-O'Neill A, Schatz DA, Thomas N, Bernhardt JM, Cook CL, Haller MJ, Bernier AV, Silverstein JH, Westen SC, Elder JH.

JMIR Diabetes. 2019 Aug 6;4(3):e13724. doi: 10.2196/13724.

7.

Is It Time to Prioritize Diabetes Prevention in Practice?

Mainous AG 3rd, Schatz DA.

J Am Board Fam Med. 2019 Jul-Aug;32(4):457-459. doi: 10.3122/jabfm.2019.04.190114. No abstract available.

8.

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.

Haller MJ, Long SA, Blanchfield JL, Schatz DA, Skyler JS, Krischer JP, Bundy BN, Geyer SM, Warnock MV, Miller JL, Atkinson MA, Becker DJ, Baidal DA, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Herold KC, Marks JB, Moran A, Rodriguez H, Russell WE, Wilson DM, Greenbaum CJ; Type 1 Diabetes TrialNet ATG-GCSF Study Group.

Diabetes. 2019 Jun;68(6):1267-1276. doi: 10.2337/db19-0057. Epub 2019 Apr 9.

9.

Enhanced Understanding of the Natural History of Pre-Type 1 Diabetes: Fundamental to Prevention.

Bruggeman BS, Schatz DA.

Pediatr Endocrinol Rev. 2019 Mar;16(3):359-368. doi: 10.17458/per.vol16.2019.bs.pretype1diabetes.

PMID:
30888126
10.

Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes.

Campbell-Thompson ML, Filipp SL, Grajo JR, Nambam B, Beegle R, Middlebrooks EH, Gurka MJ, Atkinson MA, Schatz DA, Haller MJ.

Diabetes Care. 2019 Feb;42(2):281-287. doi: 10.2337/dc18-1512. Epub 2018 Dec 14.

11.

Objectively Measured Adherence in Adolescents With Type 1 Diabetes on Multiple Daily Injections and Insulin Pump Therapy.

Westen SC, Warnick JL, Albanese-O'Neill A, Schatz DA, Haller MJ, Entessari M, Janicke DM.

J Pediatr Psychol. 2019 Jan 1;44(1):21-31. doi: 10.1093/jpepsy/jsy064.

PMID:
30184209
12.

Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes.

Haller MJ, Schatz DA, Skyler JS, Krischer JP, Bundy BN, Miller JL, Atkinson MA, Becker DJ, Baidal D, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Herold KC, Marks JB, Moran A, Rodriguez H, Russell W, Wilson DM, Greenbaum CJ; Type 1 Diabetes TrialNet ATG-GCSF Study Group.

Diabetes Care. 2018 Sep;41(9):1917-1925. doi: 10.2337/dc18-0494. Epub 2018 Jul 16.

13.

Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience.

Greenbaum CJ, Speake C, Krischer J, Buckner J, Gottlieb PA, Schatz DA, Herold KC, Atkinson MA.

Diabetes. 2018 Jul;67(7):1216-1225. doi: 10.2337/db18-0065. Epub 2018 May 16.

14.

Understanding Pre-Type 1 Diabetes: The Key to Prevention.

Jacobsen LM, Haller MJ, Schatz DA.

Front Endocrinol (Lausanne). 2018 Mar 6;9:70. doi: 10.3389/fendo.2018.00070. eCollection 2018. Review.

15.

Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling.

Perry DJ, Wasserfall CH, Oram RA, Williams MD, Posgai A, Muir AB, Haller MJ, Schatz DA, Wallet MA, Mathews CE, Atkinson MA, Brusko TM.

Sci Rep. 2018 Mar 14;8(1):4529. doi: 10.1038/s41598-018-22574-5.

16.

Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial.

Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group, Krischer JP, Schatz DA, Bundy B, Skyler JS, Greenbaum CJ.

JAMA. 2017 Nov 21;318(19):1891-1902. doi: 10.1001/jama.2017.17070.

17.

Hospital time prior to death and pancreas histopathology: implications for future studies.

Kusmartseva I, Beery M, Philips T, Selman S, Jadhav P, Wasserfall C, Muller A, Pugliese A, Longmate JA, Schatz DA, Atkinson MA, Kaddis JS.

Diabetologia. 2018 Apr;61(4):954-958. doi: 10.1007/s00125-017-4494-x. Epub 2017 Nov 11.

18.

Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity.

Kemppainen KM, Vehik K, Lynch KF, Larsson HE, Canepa RJ, Simell V, Koletzko S, Liu E, Simell OG, Toppari J, Ziegler AG, Rewers MJ, Lernmark Å, Hagopian WA, She JX, Akolkar B, Schatz DA, Atkinson MA, Blaser MJ, Krischer JP, Hyöty H, Agardh D, Triplett EW; Environmental Determinants of Diabetes in the Young (TEDDY) Study Group.

JAMA Pediatr. 2017 Dec 1;171(12):1217-1225. doi: 10.1001/jamapediatrics.2017.2905.

19.

High Illicit Drug Abuse and Suicide in Organ Donors With Type 1 Diabetes.

Jacobsen LM, Haller MJ, Parish A, Gurka MJ, Levine SR, Wasserfall C, Campbell-Thompson M, Kaddis J, Pugliese A, Atkinson MA, Schatz DA.

Diabetes Care. 2017 Sep;40(9):e122-e123. doi: 10.2337/dc17-0996. Epub 2017 Jul 5. No abstract available.

PMID:
28679687
20.

Type 1 diabetes mellitus.

Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark Å.

Nat Rev Dis Primers. 2017 Mar 30;3:17016. doi: 10.1038/nrdp.2017.16. Review.

PMID:
28358037
21.

Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.

Posgai AL, Wasserfall CH, Kwon KC, Daniell H, Schatz DA, Atkinson MA.

Sci Rep. 2017 Feb 13;7:42372. doi: 10.1038/srep42372.

22.

Factors That Influence the Quality of RNA From the Pancreas of Organ Donors.

Philips T, Kusmartseva I, Gerling IC, Campbell-Thompson M, Wasserfall C, Pugliese A, Longmate JA, Schatz DA, Atkinson MA, Kaddis JS.

Pancreas. 2017 Feb;46(2):252-259. doi: 10.1097/MPA.0000000000000717.

23.

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.

Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L, Groop PH, Handelsman Y, Insel RA, Mathieu C, McElvaine AT, Palmer JP, Pugliese A, Schatz DA, Sosenko JM, Wilding JP, Ratner RE.

Diabetes. 2017 Feb;66(2):241-255. doi: 10.2337/db16-0806. Epub 2016 Dec 15. Review.

24.

Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.

Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Perry DJ, Schultz AR, Hulme MA, Shuster JJ, Zou B, Wasserfall CH, Posgai AL, Mathews CE, Brusko TM, Atkinson MA, Schatz DA.

Diabetes. 2016 Dec;65(12):3765-3775. Epub 2016 Sep 26.

25.

Diagnostic Dilemma: Clinical and Histological Abnormalities in a Hispanic Patient With Diabetes.

Jacobsen LM, Posgai AL, Campbell-Thompson M, Schatz DA.

Diabetes Care. 2016 Sep;39(9):1650-2. doi: 10.2337/dc16-0711. No abstract available.

PMID:
27555624
26.

The DIPP project: 20 years of discovery in type 1 diabetes.

Haller MJ, Schatz DA.

Pediatr Diabetes. 2016 Jul;17 Suppl 22:5-7. doi: 10.1111/pedi.12398. No abstract available.

PMID:
27411430
27.

Presumptive Type 1 Diabetes With Comorbidities and Rapid Progression Despite Numerous Insulin-Positive Islets.

Jacobsen LM, Atkinson MA, Campbell-Thompson M, Schatz DA.

Diabetes Care. 2016 Jul;39(7):1292-4. doi: 10.2337/dc16-0737. No abstract available.

PMID:
27330131
28.

Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study.

Vehik K, Lynch KF, Schatz DA, Akolkar B, Hagopian W, Rewers M, She JX, Simell O, Toppari J, Ziegler AG, Lernmark Å, Bonifacio E, Krischer JP; TEDDY Study Group.

Diabetes Care. 2016 Sep;39(9):1535-42. doi: 10.2337/dc16-0181. Epub 2016 Jun 16.

29.

Validation of a rapid type 1 diabetes autoantibody screening assay for community-based screening of organ donors to identify subjects at increased risk for the disease.

Wasserfall C, Montgomery E, Yu L, Michels A, Gianani R, Pugliese A, Nierras C, Kaddis JS, Schatz DA, Bonifacio E, Atkinson MA.

Clin Exp Immunol. 2016 Jul;185(1):33-41. doi: 10.1111/cei.12797. Epub 2016 May 4.

30.

Identification of tissue-specific cell death using methylation patterns of circulating DNA.

Lehmann-Werman R, Neiman D, Zemmour H, Moss J, Magenheim J, Vaknin-Dembinsky A, Rubertsson S, Nellgård B, Blennow K, Zetterberg H, Spalding K, Haller MJ, Wasserfall CH, Schatz DA, Greenbaum CJ, Dorrell C, Grompe M, Zick A, Hubert A, Maoz M, Fendrich V, Bartsch DK, Golan T, Ben Sasson SA, Zamir G, Razin A, Cedar H, Shapiro AM, Glaser B, Shemer R, Dor Y.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1826-34. doi: 10.1073/pnas.1519286113. Epub 2016 Mar 14.

31.

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.

Sherr JL, Ruedy KJ, Foster NC, Piché CA, Dulude H, Rickels MR, Tamborlane WV, Bethin KE, DiMeglio LA, Fox LA, Wadwa RP, Schatz DA, Nathan BM, Marcovina SM, Rampakakis E, Meng L, Beck RW; T1D Exchange Intranasal Glucagon Investigators.

Diabetes Care. 2016 Apr;39(4):555-62. doi: 10.2337/dc15-1606. Epub 2016 Feb 16.

32.

Pancreatic duct hyperplasia/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et al [letter] and Saisho Y [letter].

Campbell-Thompson ML, Schatz DA, Kaddis JS, Atkinson MA.

Diabetologia. 2016 Apr;59(4):870-2. doi: 10.1007/s00125-016-3889-4. Epub 2016 Feb 9. No abstract available.

33.

Educational Needs and Technological Preferences of Fathers of Youth With Type 1 Diabetes.

Albanese-O'Neill A, Schatz DA, Bernhardt JM, Elder JH.

Diabetes Educ. 2016 Apr;42(2):209-19. doi: 10.1177/0145721716628649. Epub 2016 Feb 5.

PMID:
26850045
34.

Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry.

Fox LA, Mubasher M, Wolfsdorf JI, Buckingham BA, Peters AL, Tamborlane WV, Schatz DA, Maahs DM, Miller KM, Beck RW; T1D Exchange Clinic Network.

J Diabetes. 2016 Nov;8(6):834-838. doi: 10.1111/1753-0407.12363. Epub 2016 Feb 24.

PMID:
26663683
35.

Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes.

Campbell-Thompson M, Fu A, Kaddis JS, Wasserfall C, Schatz DA, Pugliese A, Atkinson MA.

Diabetes. 2016 Mar;65(3):719-31. doi: 10.2337/db15-0779. Epub 2015 Nov 18.

36.

Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report.

Wherrett DK, Chiang JL, Delamater AM, DiMeglio LA, Gitelman SE, Gottlieb PA, Herold KC, Lovell DJ, Orchard TJ, Ryan CM, Schatz DA, Wendler DS, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group.

Diabetes Care. 2015 Oct;38(10):1975-85. doi: 10.2337/dc15-1429. Review.

37.

Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.

Insel RA, Dunne JL, Atkinson MA, Chiang JL, Dabelea D, Gottlieb PA, Greenbaum CJ, Herold KC, Krischer JP, Lernmark Å, Ratner RE, Rewers MJ, Schatz DA, Skyler JS, Sosenko JM, Ziegler AG.

Diabetes Care. 2015 Oct;38(10):1964-74. doi: 10.2337/dc15-1419. Review.

38.

Screening for T1D risk to reduce DKA is not economically viable.

Meehan C, Fout B, Ashcraft J, Schatz DA, Haller MJ.

Pediatr Diabetes. 2015 Dec;16(8):565-72. doi: 10.1111/pedi.12313. Epub 2015 Sep 22.

PMID:
26392298
39.

The influence of type 1 diabetes on pancreatic weight.

Campbell-Thompson ML, Kaddis JS, Wasserfall C, Haller MJ, Pugliese A, Schatz DA, Shuster JJ, Atkinson MA.

Diabetologia. 2016 Jan;59(1):217-221. doi: 10.1007/s00125-015-3752-z. Epub 2015 Sep 10.

40.

Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany.

Maahs DM, Hermann JM, Holman N, Foster NC, Kapellen TM, Allgrove J, Schatz DA, Hofer SE, Campbell F, Steigleder-Schweiger C, Beck RW, Warner JT, Holl RW; National Paediatric Diabetes Audit and the Royal College of Paediatrics and Child Health, the DPV Initiative, and the T1D Exchange Clinic Network.

Diabetes Care. 2015 Oct;38(10):1876-82. doi: 10.2337/dc15-0780. Epub 2015 Aug 17.

PMID:
26283737
41.

Erratum: Disparities in Social Support for Youths With Type 1 Diabetes. Clinical Diabetes 2015;33:62-69.

Walker AF, Schatz DA, Johnson C, Silverstein JH, Rohrs HJ.

Clin Diabetes. 2015 Jul;33(3):159. doi: 10.2337/diaclin.33.3.159.

42.

Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry.

Clements MA, Foster NC, Maahs DM, Schatz DA, Olson BA, Tsalikian E, Lee JM, Burt-Solorzano CM, Tamborlane WV, Chen V, Miller KM, Beck RW; T1D Exchange Clinic Network.

Pediatr Diabetes. 2016 Aug;17(5):327-36. doi: 10.1111/pedi.12295. Epub 2015 Jul 8.

43.

Using photography as a method to explore adolescent challenges and resilience in type 1 diabetes.

Walker AF, Johnson C, Schatz DA, Silverstein JH, Lyles S, Rohrs HJ.

Diabetes Spectr. 2015 May;28(2):92-8. doi: 10.2337/diaspect.28.2.92.

44.

Puppy Love, Adolescence, and Chronic Illness: The Importance of Pets for Youth with Type 1 Diabetes.

Walker AF, Johnson C, Schatz DA, Silverstein JH, Rohrs HJ.

J Patient Exp. 2015 May;2(1):21-24. doi: 10.1177/237437431500200105. Epub 2015 May 1.

45.

Disparities in social support systems for youths with type 1 diabetes.

Walker AF, Schatz DA, Johnson C, Silverstein JH, Rohrs HJ.

Clin Diabetes. 2015 Apr;33(2):62-9. doi: 10.2337/diaclin.33.2.62. Erratum in: Clin Diabetes. 2015 Jul;33(3):159.

46.

The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.

Krischer JP, Lynch KF, Schatz DA, Ilonen J, Lernmark Å, Hagopian WA, Rewers MJ, She JX, Simell OG, Toppari J, Ziegler AG, Akolkar B, Bonifacio E; TEDDY Study Group.

Diabetologia. 2015 May;58(5):980-7. doi: 10.1007/s00125-015-3514-y. Epub 2015 Feb 10.

47.

Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes.

Kemppainen KM, Ardissone AN, Davis-Richardson AG, Fagen JR, Gano KA, León-Novelo LG, Vehik K, Casella G, Simell O, Ziegler AG, Rewers MJ, Lernmark Å, Hagopian W, She JX, Krischer JP, Akolkar B, Schatz DA, Atkinson MA, Triplett EW; TEDDY Study Group.

Diabetes Care. 2015 Feb;38(2):329-32. doi: 10.2337/dc14-0850. Epub 2014 Dec 17.

48.

Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes.

Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Rosenthal SM, Shuster JJ, Zou B, Brusko TM, Hulme MA, Wasserfall CH, Mathews CE, Atkinson MA, Schatz DA.

J Clin Invest. 2015 Jan;125(1):448-55. doi: 10.1172/JCI78492. Epub 2014 Dec 15.

49.

Refractory peritonitis: a role for imaging.

Schatz DA, Brewster UC.

Semin Dial. 2014 Sep-Oct;27(5):504. doi: 10.1111/sdi.12289. No abstract available.

PMID:
25204881
50.

IgG4 antibodies in autoimmune polyglandular disease and IgG4-related endocrinopathies: pathophysiology and clinical characteristics.

Nambam B, Winter WE, Schatz DA.

Curr Opin Pediatr. 2014 Aug;26(4):493-9. doi: 10.1097/MOP.0000000000000107. Review.

PMID:
24905103

Supplemental Content

Loading ...
Support Center